News
Gene Hackman Signed His Will 20 Years Ago, Making It 'Exponentially Harder' to Contest: Legal Expert
Gene Hackman's late wife Betsy was named the successor trustee to his living trust, but it remains unclear whom the beneficiaries of that trust are Gene Hackman and his wife Betsy signed their ...
The late Gene Hackman made no mention in his will of his three children, opting instead to leave his entire $80 million fortune to his wife, pianist Betsy Arakawa, who died days before her Oscar ...
For the first time, doctors have treated a baby born with a rare, life-threatening genetic disorder with a gene-editing therapy scientists tailored to specifically repair his unique mutation.
Key details around the investigation into the grim deaths of Gene Hackman and his wife Betsy Arakawa are set to be released, but the most ghastly video and pictures will stay sealed, a New Mexico ...
Details continue to emerge about the deaths of Gene Hackman, his wife Betsy Arakawa and their dog after they were found dead in their home in New Mexico on Feb. 26. Over a week after they were ...
Gene Hackman's cause of death was heart disease, wife died of hantavirus days earlier, officials say
New Mexico officials have announced the cause of death for actor Gene Hackman and his wife Betsy Arakawa, a week after they were found dead at their home in Santa Fe. Hackman died of heart disease ...
Gene and Betsy were laid to rest and remembered in a small, private memorial held recently in Santa Fe Gene Hackman died of hypertensive and atherosclerotic cardiovascular disease, while his wife ...
The timeline for the deaths of actor Gene Hackman and wife Betsy Arakawa has been changed after a doctor revealed Arakawa called them after the time of death investigators previously estimated.
Venture capital investment in gene therapies fell to $1.4 billion in 2024 from 2021 peak of $8.2 billion Total global biopharma venture funding rose to $27 billion in 2024 from $23.2 billion in ...
CRISPR gene-editing technology offers curative potential for genetic diseases. The gene-editing market is projected to reach $30.8 billion by 2032. Top gene-editing pioneers include Intellia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results